Tag: narrow therapeutic index

Combination NTI Drugs and Generic Availability: Coverage and Gaps

Combination NTI drugs-medications with narrow therapeutic windows-pose serious risks when switched to generics. With no approved generic combinations in the U.S., patients face higher costs, dangerous variability, and preventable adverse events.

How to Talk to Patients About Switching to Generic NTI Drugs

When switching patients to generic NTI drugs, clear communication is critical. Learn what to say, when to monitor, and how to build trust to ensure safety and adherence.